Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial.

Davey Daniel; Vladimer Kuchava; Igor Bondarenko; Oleksandr Ivashchuk; Sreekanth Reddy; Jana Jaal; Iveta Kudaba; Lowell Hart; Amiran Matitashvili; Yili Pritchett; Shannon R Morris; Jessica A Sorrentino; Joyce M Antal; Jerome Goldschmidt

doi:10.1002/IJC.33453

Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial.

Davey Daniel
, Vladimer Kuchava
, Igor Bondarenko
, Oleksandr Ivashchuk
, Sreekanth Reddy
, Jana Jaal
, Iveta Kudaba
, Lowell Hart
, Amiran Matitashvili
, Yili Pritchett
, Shannon R Morris
, Jessica A Sorrentino
, Joyce M Antal
, Jerome Goldschmidt

Sarah Cannon Research Institute
LTD Institute of Clinical Oncology, Tbilisi, Georgia.
Dnipropetrovsk Medical Academy, Dnipro, Ukraine.
Chernivtsi Regional Clinical Oncology Centre, Chernivtsi, Ukraine.
Northside Hospital
University of Tartu
Latvian Oncology Centre, Riga East University Hospital, Riga, Latvia.
Florida Cancer Specialists, Fort Myers, Florida, USA.
LTD Cancer Research Centre, Tbilisi, Georgia.
Research Triangle Park
Blue Ridge Cancer Care, Blacksburg, Virginia, USA.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	International Journal of Cancer
Volume	148
Issue number	10
DOIs	https://doi.org/10.1002/IJC.33453
State	Published - May 15 2021
Externally published	Yes

Disciplines

Medicine and Health Sciences
Gastroenterology
Internal Medicine

Access to Document

10.1002/IJC.33453License: Unspecified

Cite this

Daniel, D., Kuchava, V., Bondarenko, I., Ivashchuk, O., Reddy, S., Jaal, J., Kudaba, I., Hart, L., Matitashvili, A., Pritchett, Y., Morris, S. R., Sorrentino, J. A., Antal, J. M., & Goldschmidt, J. (2021). Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial. International Journal of Cancer, 148(10). https://doi.org/10.1002/IJC.33453

Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial. / Daniel, Davey; Kuchava, Vladimer; Bondarenko, Igor et al.
In: International Journal of Cancer, Vol. 148, No. 10, 15.05.2021.

Research output: Contribution to journal › Article › peer-review

Daniel, D, Kuchava, V, Bondarenko, I, Ivashchuk, O, Reddy, S, Jaal, J, Kudaba, I, Hart, L, Matitashvili, A, Pritchett, Y, Morris, SR, Sorrentino, JA, Antal, JM & Goldschmidt, J 2021, 'Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial.', International Journal of Cancer, vol. 148, no. 10. https://doi.org/10.1002/IJC.33453

@article{7ea4799e573747569a1ef3b315dd37da,

title = "Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial.",

author = "Davey Daniel and Vladimer Kuchava and Igor Bondarenko and Oleksandr Ivashchuk and Sreekanth Reddy and Jana Jaal and Iveta Kudaba and Lowell Hart and Amiran Matitashvili and Yili Pritchett and Morris, \{Shannon R\} and Sorrentino, \{Jessica A\} and Antal, \{Joyce M\} and Jerome Goldschmidt",

note = "Trilaciclib is an intravenous CDK4/6 inhibitor administered prior to chemotherapy to preserve haematopoietic stem and progenitor cells and immune system function from chemotherapy-induced damage (mye...",

year = "2021",

month = may,

day = "15",

doi = "10.1002/IJC.33453",

language = "American English",

volume = "148",

journal = "International Journal of Cancer",

issn = "1097-0215",

publisher = "Wiley",

number = "10",

}

TY - JOUR

T1 - Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial.

AU - Daniel, Davey

AU - Kuchava, Vladimer

AU - Bondarenko, Igor

AU - Ivashchuk, Oleksandr

AU - Reddy, Sreekanth

AU - Jaal, Jana

AU - Kudaba, Iveta

AU - Hart, Lowell

AU - Matitashvili, Amiran

AU - Pritchett, Yili

AU - Morris, Shannon R

AU - Sorrentino, Jessica A

AU - Antal, Joyce M

AU - Goldschmidt, Jerome

N1 - Trilaciclib is an intravenous CDK4/6 inhibitor administered prior to chemotherapy to preserve haematopoietic stem and progenitor cells and immune system function from chemotherapy-induced damage (mye...

PY - 2021/5/15

Y1 - 2021/5/15

UR - https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33453

U2 - 10.1002/IJC.33453

DO - 10.1002/IJC.33453

M3 - Article

SN - 1097-0215

VL - 148

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 10

ER -

Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial.

Disciplines

Access to Document

Other files and links

Cite this